Your browser doesn't support javascript.
loading
Factors influencing alopecia areata treatment decisions: A qualitative assessment.
Han, Jane J; Faletsky, Adam; Ghatnekar, Shilpa; Lee, Karen J; Pérez-Chada, Lourdes M; Li, Sara J; Manjaly, Priya; Senna, Maryanne M; Huang, Kathie P; Mostaghimi, Arash.
Afiliación
  • Han JJ; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Faletsky A; Stritch School of Medicine, Loyola University, Maywood, Illinois.
  • Ghatnekar S; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Lee KJ; School of Medicine, Tufts University, Boston, Massachusetts.
  • Pérez-Chada LM; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Li SJ; School of Medicine, Tufts University, Boston, Massachusetts.
  • Manjaly P; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Senna MM; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Huang KP; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Mostaghimi A; School of Medicine, Boston University, Boston, Massachusetts.
JAAD Int ; 10: 77-83, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36688102
ABSTRACT

Background:

Alopecia areata (AA) is a disease of hair loss in which patients may benefit from comprehensive understanding of AA's disease process and therapeutic options during treatment decision-making.

Objective:

Determine factors influencing patients' AA treatment decision-making.

Methods:

Qualitative interviews were conducted using semi-structured interview guides. Interviews were coded using inductive thematic analysis.

Results:

Twenty-one participants with AA were interviewed. Coding interrater reliability was κ = 0.87-0.91, indicating strong-almost perfect agreement. Participants faced multiple barriers, including lack of access to health care (n = 10, 47.6%) and lack of transparency about their condition and treatment options (n = 9, 42.9%). Information about AA was sought from primarily the internet (n = 15, 71.4%) and physician recommendation (n = 15, 71.4%). When choosing AA treatments, patients often considered treatment efficacy (n = 21, 100%), safety (n = 21, 100%), and convenience of use (n = 20, 95.2%).

Limitations:

Referral and regional biases may be present and limit generalizability.

Conclusions:

Patients with AA face various challenges including medical uncertainty and lack of information. Patients need trustworthy and accessible sources of information regarding their treatment that also take into consideration their preferences and values.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: JAAD Int Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: JAAD Int Año: 2023 Tipo del documento: Article